450 related articles for article (PubMed ID: 21680910)
21. Global changes in gene expression of Barrett's esophagus compared to normal squamous esophagus and gastric cardia tissues.
Hyland PL; Hu N; Rotunno M; Su H; Wang C; Wang L; Pfeiffer RM; Gherman B; Giffen C; Dykes C; Dawsey SM; Abnet CC; Johnson KM; Acosta RD; Young PE; Cash BD; Taylor PR
PLoS One; 2014; 9(4):e93219. PubMed ID: 24714516
[TBL] [Abstract][Full Text] [Related]
22. Barrett's oesophagus with indefinite for dysplasia shows high rates of prevalent and incident neoplasia in a UK multicentre cohort.
Kopczynska M; Ratcliffe E; Yalamanchili H; Thompson A; Nimri A; Britton J; Ang Y
J Clin Pathol; 2023 Dec; 76(12):847-854. PubMed ID: 36150885
[TBL] [Abstract][Full Text] [Related]
23. Predicting Incident Adenocarcinoma of the Esophagus or Gastric Cardia Using Machine Learning of Electronic Health Records.
Rubenstein JH; Fontaine S; MacDonald PW; Burns JA; Evans RR; Arasim ME; Chang JW; Firsht EM; Hawley ST; Saini SD; Wallner LP; Zhu J; Waljee AK
Gastroenterology; 2023 Dec; 165(6):1420-1429.e10. PubMed ID: 37597631
[TBL] [Abstract][Full Text] [Related]
24. Family history of gastric mucosal abnormality and the risk of gastric cancer: a population-based observational study.
Song H; Ekheden IG; Ploner A; Ericsson J; Nyren O; Ye W
Int J Epidemiol; 2018 Apr; 47(2):440-449. PubMed ID: 29161426
[TBL] [Abstract][Full Text] [Related]
25. Serum leptin and adiponectin levels and risk of Barrett's esophagus and intestinal metaplasia of the gastroesophageal junction.
Thompson OM; Beresford SA; Kirk EA; Bronner MP; Vaughan TL
Obesity (Silver Spring); 2010 Nov; 18(11):2204-11. PubMed ID: 20111023
[TBL] [Abstract][Full Text] [Related]
26. Incidence and Prediction of Unrelated Mortality After Successful Endoscopic Eradication Therapy for Barrett's Neoplasia.
van Munster SN; Verheij EPD; Ozdemir Ö; Toes-Zoutendijk E; Lansdorp-Vogelaar I; Nieuwenhuis EA; Cotton CC; Weusten BLAM; Alvarez Herrero L; Alkhalaf A; Schenk BE; Schoon EJ; Curvers WL; Koch AD; de Jonge PF; Tang TJ; Nagengast WB; Westerhof J; Houben MHMG; Shaheen NJ; Bergman JJGHM; Pouw RE
Gastroenterology; 2024 Jun; 166(6):1058-1068. PubMed ID: 38447738
[TBL] [Abstract][Full Text] [Related]
27. An Automated Tissue Systems Pathology Test Can Standardize the Management and Improve Health Outcomes for Patients With Barrett's Esophagus.
Duits LC; Khoshiwal AM; Frei NF; Pouw RE; Smolko C; Arora M; Siegel JJ; Critchley-Thorne RJ; Bergman JJGHM;
Am J Gastroenterol; 2023 Nov; 118(11):2025-2032. PubMed ID: 37307529
[TBL] [Abstract][Full Text] [Related]
28. A pooled analysis of dietary sugar/carbohydrate intake and esophageal and gastric cardia adenocarcinoma incidence and survival in the USA.
Li N; Petrick JL; Steck SE; Bradshaw PT; McClain KM; Niehoff NM; Engel LS; Shaheen NJ; Risch HA; Vaughan TL; Wu AH; Gammon MD
Int J Epidemiol; 2017 Dec; 46(6):1836-1846. PubMed ID: 29040685
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of Barrett esophagus in first-degree relatives of patients with esophageal adenocarcinoma.
Juhasz A; Mittal SK; Lee TH; Deng C; Chak A; Lynch HT
J Clin Gastroenterol; 2011; 45(10):867-71. PubMed ID: 21617543
[TBL] [Abstract][Full Text] [Related]
30. Incidence and survival of oesophageal and gastric cancer in England between 1998 and 2007, a population-based study.
Coupland VH; Allum W; Blazeby JM; Mendall MA; Hardwick RH; Linklater KM; Møller H; Davies EA
BMC Cancer; 2012 Jan; 12():11. PubMed ID: 22239958
[TBL] [Abstract][Full Text] [Related]
31. Assessment of familiality, obesity, and other risk factors for early age of cancer diagnosis in adenocarcinomas of the esophagus and gastroesophageal junction.
Chak A; Falk G; Grady WM; Kinnard M; Elston R; Mittal S; King JF; Willis JE; Kondru A; Brock W; Barnholtz-Sloan J
Am J Gastroenterol; 2009 Aug; 104(8):1913-21. PubMed ID: 19491834
[TBL] [Abstract][Full Text] [Related]
32. Opium: an emerging risk factor for gastric adenocarcinoma.
Shakeri R; Malekzadeh R; Etemadi A; Nasrollahzadeh D; Aghcheli K; Sotoudeh M; Islami F; Pourshams A; Pawlita M; Boffetta P; Dawsey SM; Abnet CC; Kamangar F
Int J Cancer; 2013 Jul; 133(2):455-61. PubMed ID: 23319416
[TBL] [Abstract][Full Text] [Related]
33. Screening and Preventive Strategies in Esophagogastric Cancer.
Zakko L; Lutzke L; Wang KK
Surg Oncol Clin N Am; 2017 Apr; 26(2):163-178. PubMed ID: 28279462
[TBL] [Abstract][Full Text] [Related]
34. Field population-based blocking treatment of esophageal epithelia dysplasia.
Hou J; Lin PZ; Chen ZF; Ding ZW; Li SS; Men FS; Guo LP; He YT; Qiao CY; Guo CL; Duan JP; Wen DG
World J Gastroenterol; 2002 Jun; 8(3):418-22. PubMed ID: 12046061
[TBL] [Abstract][Full Text] [Related]
35. Dating the rise of esophageal adenocarcinoma: analysis of Connecticut Tumor Registry data, 1940-2007.
Abrams JA; Sharaiha RZ; Gonsalves L; Lightdale CJ; Neugut AI
Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):183-6. PubMed ID: 21127287
[TBL] [Abstract][Full Text] [Related]
36. Tumor suppressor gene p16 and Rb expression in gastric cardia precancerous lesions from subjects at a high incidence area in northern China.
Zhou Y; Gao SS; Li YX; Fan ZM; Zhao X; Qi YJ; Wei JP; Zou JX; Liu G; Jiao LH; Bai YM; Wang LD
World J Gastroenterol; 2002 Jun; 8(3):423-5. PubMed ID: 12046062
[TBL] [Abstract][Full Text] [Related]
37. Relationship between ABO blood groups and carcinoma of esophagus and cardia in Chaoshan inhabitants of China.
Su M; Lu SM; Tian DP; Zhao H; Li XY; Li DR; Zheng ZC
World J Gastroenterol; 2001 Oct; 7(5):657-61. PubMed ID: 11819849
[TBL] [Abstract][Full Text] [Related]
38. Diabetes and gastric cancer incidence and mortality in the Asia Cohort Consortium: A pooled analysis of more than a half million participants.
De la Torre K; Song M; Abe SK; Rahman MS; Islam MR; Saito E; Min S; Huang D; Chen Y; Gupta PC; Sawada N; Tamakoshi A; Shu XO; Wen W; Sakata R; Kim J; Nagata C; Ito H; Park SK; Shin MH; Pednekar MS; Tsugane S; Kimura T; Gao YT; Cai H; Wada K; Oze I; Shin A; Ahn YO; Ahsan H; Boffetta P; Chia KS; Matsuo K; Qiao YL; Rothman N; Zheng W; Inoue M; Kang D
J Diabetes; 2024 Jun; 16(6):e13561. PubMed ID: 38751364
[TBL] [Abstract][Full Text] [Related]
39. Age scope of high-risk population for esophageal cancer in Ci county.
Chen ZF; Hou J; Ding ZW; Guo CL; Qiao CY; Song GH; Li SS; Zhang JH; He YT
World J Gastroenterol; 2005 Mar; 11(12):1818-21. PubMed ID: 15793872
[TBL] [Abstract][Full Text] [Related]
40. International variation in oesophageal and gastric cancer survival 2012-2014: differences by histological subtype and stage at diagnosis (an ICBP SURVMARK-2 population-based study).
Arnold M; Morgan E; Bardot A; Rutherford MJ; Ferlay J; Little A; Møller B; Bucher O; De P; Woods RR; Saint-Jacques N; Gavin AT; Engholm G; Achiam MP; Porter G; Walsh PM; Vernon S; Kozie S; Ramanakumar AV; Lynch C; Harrison S; Merrett N; O'Connell DL; Mala T; Elwood M; Zalcberg J; Huws DW; Ransom D; Bray F; Soerjomataram I
Gut; 2022 Aug; 71(8):1532-1543. PubMed ID: 34824149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
